Articles by Erin Slifka

The Securities and Exchange Commission alleged that a researcher for the company manipulated trial data to make its drug results look more promising.

The owner of Silicon Valley’s Done Global was arrested, but the telehealth company’s staff in China still provides easy access to stimulants for Americans.

The car-parts supplier cut its sales and profitability guidance for the year, as market uncertainty in Europe and high car inventories in North America weigh on vehicle production.

LVMH is investing in Moncler in a transaction that gives the luxury heavyweight a seat on the board of the Italian fashion company, best known for its pricey puffer jackets.

A trial in the case was set to begin Sept. 30, while Smartmatic has a separate suit pending against Fox News.

Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.

The e-commerce giant is one of the biggest U.S. employers to respond to government pressure to make overdose medicine more available in the workplace.

News Corp-controlled REA Group has made a fourth proposal to buy British peer Rightmove for roughly $8.3 billion in cash and shares, and urged its board to enter into talks.

The impact is, at best, indirect and uncertain, a finance professor argues. But there are better ways to accomplish what advocates are seeking.

The National Transportation Safety Board issued urgent recommendations for about 350 Boeing 737 jets globally.